| Changing the learning curve in novice laparoscopists: Incorporating direct visualization into the simulation training program MT Dawidek, VA Roach, MC Ott, TD Wilson Journal of Surgical Education 74 (1), 30-36, 2017 | 16 | 2017 |
| Assessing time of full renal recovery following minimally invasive partial nephrectomy MT Dawidek, E Chan, SL Boyle, A Sener, PP Luke Urology 112, 98-102, 2018 | 14 | 2018 |
| Renal lymphangiectasia in the transplanted kidney: Case series and literature review MT Dawidek, S Aquil, R Alogaili, M Gabril, M Moussa, A Sener, PP Luke Transplantation 104 (1), 172-175, 2020 | 11 | 2020 |
| Prophylactic tamsulosin and urinary retention rates following elective colorectal surgery: A retrospective cohort study A Ghuman, MT Dawidek, MS Athwal, N Kasteel, CJ Brown, ... International Journal of Colorectal Disease 37, 209–214, 2021 | 5 | 2021 |
| PD60-01 DEFINITIVE RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: THE CANADIAN MULTICENTER EXPERIENCE R Kool, G Marcq, I Busca, H Abdi, R Breau, G Fervaha, R Siemens, ... The Journal of Urology 203 (Supplement 4), e1273-e1273, 2020 | 4 | 2020 |
| Clinical validation of an audio-based uroflowmetry application in adult males MT Dawidek, R Singla, L Spooner, L Ho, C Nguan Canadian Urological Association Journal 16 (3), E120, 2022 | 3 | 2022 |
| Benefit of whole-pelvis radiation for patients with muscle-invasive bladder cancer: An inverse probability treatment-weighted analysis. R Kool, G Marcq, A Dragomir, GS Kulkarni, RH Breau, M Kim, I Busca, ... Journal of Clinical Oncology 41 (6_suppl), 449-449, 2023 | 2 | 2023 |
| Radiation-based therapy for muscle-invasive bladder cancer: Contemporary outcomes across tertiary centers R Kool, G Marcq, RH Breau, PC Black, B Shayegan, M Kim, I Busca, ... European Urology Oncology, 2023 | 1 | 2023 |
| PD16-09 GERMLINE BAP1 MUTATIONS AND RENAL CELL CARCINOMA: CLINICAL COURSE AND OUTCOMES FROM 11 PATIENTS LP Calderon, MT Dawidek, L Einsman, M Ganz, JA Coleman, A Goh, ... The Journal of Urology 211 (5S), e368, 2024 | | 2024 |
| PD18-01 GENOMIC CHARACTERIZATION OF RECURRENT URCC TUMORS JS Arroyave Villada, LP Calderon, C Tang, L Eismann, M Zucker, ... The Journal of Urology 211 (5S), e432, 2024 | | 2024 |
| MP30-18 MACHINE-LEARNING BASED RADIOMIC MODELS PREDICT RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CARCINOMA L Eismann, M Zucker, B Agridag, S Keene, A Kohli, S Reese, A Aulitzky, ... The Journal of Urology 211 (5S), e501, 2024 | | 2024 |
| V03-10 ENDOSCOPIC CREATION OF A NEOINFUNDIBULUM FOR AN EXCLUDED CALYX AFTER PARTIAL NEPHRECTOMY LP Calderon, MT Dawidek, M Ganz, JA Coleman, P Russo, AA Hakimi, ... The Journal of Urology 211 (5S), e194, 2024 | | 2024 |
| PD51-12 COMPREHENSIVE IMMUNOGENOMIC EVALUATION OF PATIENTS UNDERGOING CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE … S Reese, V Yarlagadda, CY Wu, F Kuo, C Tang, H Jiang, M Dawidek, ... The Journal of Urology 211 (5S), e1071, 2024 | | 2024 |
| MP56-17 LONG-TERM FOLLOW-UP AFTER NEPHRECTOMY FOR RENAL ONCOCYTOMA: RISK AND PATTERNS OF SYNCHRONOUS AND METACHRONOUS RENAL TUMOR L Eismann, LP Calderon, MT Dawidek, S Reese, KV Rivera, M Ganz, ... The Journal of Urology 211 (5S), e933, 2024 | | 2024 |
| Node positive non-clear cell renal cell carcinoma: Oncological outcomes and genomic insights L Eismann, M Zucker, M Dawidek, S Reese, LP Calderon, A Aulitzky, ... European Urology 85, S2159, 2024 | | 2024 |
| Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability … R Kool, A Dragomir, GS Kulkarni, G Marcq, RH Breau, M Kim, I Busca, ... European Urology Oncology, 2024 | | 2024 |
| PD09-02 THE IMPACT OF VARIANT HISTOLOGY ON CLINICAL OUTCOMES AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER D Halstuch, R Kool, G Marcq, RH Breau, PC Black, B Shayegan, M Kim, ... The Journal of Urology 209 (Supplement 4), e239, 2023 | | 2023 |
| MP56-01 THE EFFECT OF DIFFERENT CONCURRENT CHEMOTHERAPY REGIMENS ON OUTCOMES IN PATIENTS TREATED WITH RADIATION FOR MUSCLE INVASIVE BLADDER CANCER F Lemire, R Kool, M Gautier, R Siemens, B Shayegan, M Kim, I Busca, ... The Journal of Urology 209 (Supplement 4), e773, 2023 | | 2023 |
| MP32-11 FACTORS THAT PREDICT EARLY SALVAGE CYSTECTOMY POST-TRIMODAL THERAPY: RESULTS OF A MULTI-INSTITUTIONAL CANADIAN COHORT L Macdonald, R Kool, G Marcq, G Kulkarni, R Breau, B Shayegan, M Kim, ... The Journal of Urology 209 (Supplement 4), e444, 2023 | | 2023 |
| PD44-02 EFFECT OF GENDER ON SURVIVAL OUTCOMES AFTER TRIMODAL THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER I Macintyre, R Kool, G Marcq, R Breau, B Shayegan, M Kim, I Busca, ... The Journal of Urology 209 (Supplement 4), e1124, 2023 | | 2023 |
